Accounting for tumor heterogeneity when using CRISPR-Cas9 for cancer progression and drug sensitivity studies
Jessica Olive(Brigham and Women's Hospital), Sandra S. McAllister(Harvard University)
Cited by 17
Related Papers
Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments
|Nature Cell Biology|2019|163
Metastasis as a systemic disease: molecular insights and clinical implications
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2019|77
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells
|Breast Cancer Research|2017|43
Challenges and opportunities for modeling aging and cancer
|Cancer Cell|2023|24
Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow
|Cancer Research Communications|2024|23